EU regulator recommends dose gap of 3 weeks for Pfizer Covid-19 vaccine
The labelling of the vaccine, developed along with Germany's BioNTech and branded Comirnaty in Europe, before the change stated that the interval between the two doses should be "at least 21 days", the European Medicines Agency said
The companies said earlier on Tuesday that they had submitted approval requests for their vaccine candidates Photo: Financial Times
Europe's drugs regulator said on Thursday it now recommended that the second dose of Pfizer's Covid-19 vaccine be given three weeks after the first as many countries delay shots to vaccinate more of their population.
The labelling of the vaccine, developed along with Germany's BioNTech and branded Comirnaty in Europe, before the change stated that the interval between the two doses should be "at least 21 days", the European Medicines Agency said.
Keep updated, follow The Business Standard's Google news channel
